Navigation Links
Targeting a key enzyme with gene therapy reversed course of Alzheimer's disease in mouse models

Silencing Alzheimer's: targeting a key enzyme with gene therapy reversed course of disease in mouse modelsIn mice, that had been genetically engineered to develop Alzheimer's disease, scientists were able to reverse the rodents' memory loss by reducing the amount of an enzyme that is crucial for the development of Alzheimer's disease.

"What we are showing is a proof of principle that stopping the synthesis of a protein that is necessary for the formation of the telltale plaques reverses the progression of the disease, and more importantly, the cognitive function of these mice, which had already been impaired, has now recovered," says Inder Verma, professor in the Laboratory for Genetics at the Salk Institute for Biological Studies.

The findings, which are the result of a close collaboration between researchers at the Salk Institute and scientists at the University of California in San Diego, are reported in an advance on-line publication of Nature Neuroscience.

In the past, gene therapy has been mainly used to deliver normal genes into cells to compensate for defective versions of the gene causing disease. In their study, the researchers used gene therapy to silence a normally functioning gene. Exploiting a mechanism called RNA interference, they were able to turn down the gene that helps produce the characteristic amyloid plaques that are one of the hallmarks of Alzheimer's disease.

"Within a month of treatment, mice that had already suffered memory deficits could learn and remember how to find their way through a water maze," says co-author Robert Marr, a post-doctoral researcher in Verma's lab.

"It appears that these mice can come back from a very severe level of disease progression," adds first author Oded Singer, also at the Salk. "This is a very important finding because humans are usually diagnosed when the disease has already progressed relatively far."

But he warns that it is too early to make direct comparison
'"/>

Source:Salk Institute


Page: 1 2 3

Related biology news :

1. Best of both worlds -- Targeting a single gene could inhibit bone decay and stimulate bone growth
2. Targeting tumors the natural way
3. Targeting sugar on blood vessels may inhibit cancer growth
4. Lack of enzyme turns fat cells into fat burners
5. Scientists find missing enzyme for tuberculosis iron scavenging pathway
6. Researchers report new pro-inflammatory role for anti-inflammatory enzyme
7. Purdue researchers use enzyme to clip DNA wires
8. Scientists take aim at virulent bacteria by decoding machinery of key control enzyme
9. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
10. UCLA researchers identify key enzyme linked to childhood blindness
11. K-State professors discover enzyme responsible for creation of a beetles hard shell

Post Your Comments:
(Date:11/24/2009)... Spanish . , The presence of increased body ...ubstances in the blood, hinders the loss and maint...ect of the University of Navarra conducted by Estb... Pharmacy. , The project, entitled "A nutrigenet...ol of body weight and inflammation," examines how ...
(Date:11/23/2009)... 23, 2009 Applied mathematicians dissected the mo..., a characteristic long leaf with a saddle-like ar...edges. The simple cause of the lily,s fan-like sha... differential growthwas revealed by using an equal...Haiyi Liang, a postdoctoral student at Harvard,s S...
(Date:11/23/2009)...0 participants gathered this week for the seventh ...conference. This year,s topic, "Synthetic Biology,...cal researchers to explore the engineering, scient...ield of synthetic biology. , Bonnie L. Bassler, ...sity and this year,s conference chair, challenged ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Better control of carbon nanotube growth promising for future electronics 14325 1Better control of carbon nanotube growth promising for future electronics 14325 2Better control of carbon nanotube growth promising for future electronics 14325 3Actress Soleil Moon Frye Cant Be Punkd 3B NFL Star Terrell Owens Upset in Final Minutes of Alzheimers Association Contest 58724 1Actress Soleil Moon Frye Cant Be Punkd 3B NFL Star Terrell Owens Upset in Final Minutes of Alzheimers Association Contest 58724 2MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 1MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 2MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 3
...or food according to how stocked their nests are, ...on. , When bumblebees return to the nest from a s...ne which encourages their nest mates to also go ou... that these pheromones elicited a standard respons...s School of Biological and Chemical Sciences has s...
...ng food and water shortages in the Middle East is ...arch by an Australian climate scientist suggesting... parts of the region., Recent projections from the...raised fears that storm activity in the eastern Me...arming continues on present trends. In turn, that...
... Provide Integrated Fingerprint ...chnology, an award-winning,fingerprint biometrics ...t,Harms Software, a leading provider of management...d to begin providing M2SYS fingerprint readers and...ftware has successfully integrated M2SYS, Bio-Plug...
Other Biology News:Smells like bees' spirit 2Climate change may boost Middle East rainfall 2M2SYS Technology Innovative Fingerprint Biometrics Solution Chosen by Harms Software 2
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-Fi...announcedtheapprovalofallofits,"firstday"motionsby...e"BankruptcyCourt").deCODElastweekfiledavoluntaryp...nkruptcyCodewiththe,BankruptcyCourt. , Theord...inue,tooperateitsbusinessduringtheChapter11proceed...
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCal...alcompanyfocusedondevelopingandcommercializingnove...DiTonno,PresidentandChiefExecutiveOfficer,isschedu...onference,tobeheldDecember1-2,2009atTheNewYorkPala...enGhiglieri,ChiefFinancialOfficer,willbeavailablet...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEner...licDevelopmentAuthority(OPDA)wererecentlyawarded$2...izationBoard(CERB)inaprivate/publicpartnershiptoco...eryinLincolnCounty,WA. ,, "Thisinvestmentwillsi...ringover70greenjobstoLincolnCounty,"saidBlueMarble...
(Date:11/24/2009)...,, ,Primaryefficacyendpointhasbeenmetforpatien... , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AE...ny"),aglobalbiopharmaceuticalcompanyfocusedonendoc...acydatafromaPhase2studywithitstargetedcytotoxicpep...ithadvancedorrecurrentendometrialcancer.Inapersona...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...alia, Nov. 18 /Xinhua-PRNewswire-FirstCall/ -- Pha... had raised $11.7 million from,its Share Purchase ... of,the company were given the opportunity to purc...0 price paid by institutional investors in the,rec...icipated in the plan under which the,company will ...
...HTS, N.J., Nov. 16 Genta,Incorporated (Nasdaq: G...mination letter from the NASDAQ Stock Market stati...elisting from The NASDAQ Global,Market because the...aintain,a minimum $10,000,000 value in stockholder...)(3). The Company intends to provide a plan to,NAS...
...d., Nov. 16 Spherix Incorporated,(Nasdaq: SPEX )... $3.1,million ($0.22 per share) and $7.1 million (...nded September 30, 2007, respectively. These losse...s of 2006 due to increased,expenditures related to...,as a treatment for type 2 diabetes. The Company a...
Other Biology Technology:Pharmaxis Closes Share Purchase Plan 2Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 2Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 3Spherix Reports 3rd Quarter Earnings 2
...peptide derived from the C-terminal region catalyt...soform (PKCzeta). Specificity: Reacts with the ra...nd PKMzeta (PKCzeta II) and does not cross-react w...ve controls: mouse and rat kidney and brain homoge...
GIBCO AlbuMAX II from Invitrogen
GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen
Rabbit Anti-LSD1 / BHC110 Antibody, Unconjugated from Upstate
Biology Products: